Gustave Roussy Immune Score (GRIm-Score) is a prognostic marker in patients with resectable esophageal squamous cell carcinoma

Feng, Ji-Feng; Wang, Liang; Yang, Xun; Chen, Sheng

doi:10.7150/jca.37898



International Journal of Biological Sciences

International Journal of Medical Sciences

Theranostics

Journal of Genomics

Nanotheranostics

Global reach, higher impact

Full Text | PDF

J Cancer 2020; 11(6):1334-1340. doi:10.7150/jca.37898 This issue Cite

Research Paper

Gustave Roussy Immune Score (GRIm-Score) is a prognostic marker in patients with resectable esophageal squamous cell carcinoma

Ji-Feng Feng^1,2✉, Liang Wang¹, Xun Yang^1,2, Sheng Chen^1✉

1. Department of Thoracic Oncological Surgery, Institute of Cancer Research and Basic Medical Sciences of Chinese Academy of Sciences, Cancer Hospital of University of Chinese Academy of Sciences, Zhejiang Cancer Hospital, No.38 Guangji Road, Hangzhou 310022, China.
2. Key Laboratory Diagnosis and Treatment Technology on Thoracic Oncology, No.38 Guangji Road, Zhejiang province, Hangzhou 310022, China.

Citation:

Feng JF, Wang L, Yang X, Chen S. Gustave Roussy Immune Score (GRIm-Score) is a prognostic marker in patients with resectable esophageal squamous cell carcinoma. J Cancer 2020; 11(6):1334-1340. doi:10.7150/jca.37898. https://www.jcancer.org/v11p1334.htm

Other styles

Abstract

Background: The Gustave Roussy Immune Score (GRIm-Score) was initially reported to select patients for immunotherapy. Therefore, the purpose of the current retrospective study was to determine whether GRIm-Score, a novel nutritional and inflammatory-based prognostic score, is a useful prognostic marker in patients with esophageal squamous cell carcinoma (ESCC) undergoing surgical resection.

Methods: A retrospective single institutional study including 372 ESCC patients undergoing surgical resection was performed. The GRIm-Score was simply calculated by lactate dehydrogenase (LDH), neutrophil lymphocyte ratio (NLR) and albumin (ALB). The cancer-specific survival (CSS) was analyzed for the current study with Cox regression analyses with forward stepwise and Kaplan-Meier methods.

Results: There were 284 (76.3%) men and 88 (23.7%) women with the mean age of 59.3 ± 8.0 years (range: 36-80 years). Patient with a high GRIm-Score had poor CSS (10.3% vs. 35.0%, P < 0.001). The GRIm-Score, in multivariate analyses, instead of NLR, LDH or ALB, was an independent prognostic factor for CSS (P = 0.004).

Conclusion: The GRIm-Score was an independent prognostic marker in patients with ESCC undergoing surgical resection. Our study is also the first study to discuss the prognostic value of GRIm-Score in patients with resectable ESCC.

Keywords: esophageal squamous cell carcinoma, neutrophil to lymphocyte ratio, albumin, lactate dehydrogenase, prognosis

Citation styles

APA

Feng, J.F., Wang, L., Yang, X., Chen, S. (2020). Gustave Roussy Immune Score (GRIm-Score) is a prognostic marker in patients with resectable esophageal squamous cell carcinoma. Journal of Cancer, 11(6), 1334-1340. https://doi.org/10.7150/jca.37898.

ACS

Feng, J.F.; Wang, L.; Yang, X.; Chen, S. Gustave Roussy Immune Score (GRIm-Score) is a prognostic marker in patients with resectable esophageal squamous cell carcinoma. J. Cancer 2020, 11 (6), 1334-1340. DOI: 10.7150/jca.37898.

NLM

CSE

Feng JF, Wang L, Yang X, Chen S. 2020. Gustave Roussy Immune Score (GRIm-Score) is a prognostic marker in patients with resectable esophageal squamous cell carcinoma. J Cancer. 11(6):1334-1340.

This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.